Chronic Obstructive Pulmonary Disease (COPD) affects nearly 13% of adults in the United States, causing progressive lung damage and difficulty breathing when it goes untreated. Patients of this disorder have historically resorted to traditional treatment options such as steroids and inhalers. There may be an alternative method for managing the symptoms of this disorder. Please fill out a medical review form, or call our office in Glenview, Illinois to learn more about it.
COPD is a chronic inflammatory disease that obstructs airflow from your lungs. Although there are several types of COPD, the three primary conditions are:
In some cases, COPD is inherited, but it’s caused by smoking cigarettes in about 75% of all patients.
The symptoms caused by COPD include:
COPD has several stages of progression. Stage 1 COPD is milder. Often times, Stage 2 COPD is when symptoms start to appear. Stage 3 COPD typically causes serious changes in symptoms, lung health, and overall health and well-being.
Patients with Stage 4 COPD, also known as End-stage COPD, experience severe airflow limitations. Simple tasks such as cooking a simple meal and taking a shower leave the patient out of breath and exhausted. A patient’s lung function can drop to thirty percent or less. Stage 4 COPD is typically treated with corticosteroids, inhalers (bronchodilators) which will help open the airways. If you do have a severe flare-up you may end up hospitalized. COPD can be life-threatening and should not be taken lightly.
GIOSTAR (Global Institute of Stem Cell Therapy and Research) is home to the top experts in the field of stem cell research, and provides scientific know-how to GIOSTAR-CHICAGO. GIOSTAR-CHICAGO is an independently run facility from GIOSTAR. Involved in the field of stem cell research for almost two decades in the U.S.A, GIOSTAR has provided treatments to thousands of patients using their advanced protocols outside of the United States. GIOSTAR believes in the potential of supplementing traditional treatments for COPD (such as medication) with cellular rejuvenation therapy. Focusing solely on one particular form of treatment does not necessarily yield the desired results.
GIOSTAR opened the world’s first stem cell therapy hospital in India, and has plans to continue building stem cell treatment centers with health care partners around the world. Their goal is to develop treatments for several diseases, and offer hope to millions suffering around the globe with safe, effective and affordable healthcare.
Traditional medications used for the treatment of COPD include oral steroids, inhaled steroids, combination inhalers, pulmonary rehabilitation, and possibly oxygen therapy.
Studies show that oral steroids may help improve overall breathing function, but should be used on a short-term basis. Steroids used over a long period of time can introduce side effects and pose added risks. Side effects include increased risk of diabetes, osteoporosis, cataracts, and a compromised immune system - thereby increasing the chances of infection.
COPD is a progressive disease, and the key is to stop or slow down the progression - not simply obtain short-term symptomatic relief through the use of traditional treatments. Traditional treatments including medications, pulmonary rehabilitation, and oxygen therapy do not slow down or reverse the progression of the disease, but simply manage the symptoms.
Within the body, there are different sources of stem cells - known as the "mother" or "master" cells capable of differentiating into virtually any type of cell. As a result, it may restore function to the lungs, may help to reduce the oxygen therapy and may improve the breathing abilities. It has been documented by several scientific publications that stem cells may differentiate into a specific cell or tissue type. This suggests the possibility to develop a treatment for COPD.